We have previously reported that olanzapine injected intracerebroventricularly increases plasma glucose levels3,4 and that this hyperglycemia may involve dopamine D2 receptors, α1-adrenoceptors and histamine H1 receptors5. Here, DRD2 is linked to Hyperglycemia.